Quantbase · investment strategy
by Quantbase
This strategy takes an equal-weighted position in 10 publicly-traded companies that disclosed the most Quarter over Quarter growth in U.S. federal lobbying expenditures
Description from Quantbase
of the return and risk figures:as the source publishes them
What $10,000 would have become, from the strategy's own published history, against the S&P 500 over the same dates. The basis is labelled.
Each rule is quoted word for word from the strategy's own documents.
“takes an equal-weighted position in 10 publicly-traded companies”
“Companies with the highest quarter-over-quarter growth in corporate lobbying expenditures”
“disclosed the most Quarter over Quarter growth in U.S. federal lobbying expenditures”
“This portfolio is rebalanced at the start of every month.”
No published holdings for this strategy.
Fitted to 79 returns (composite) from 2023-10-20 to 2026-10-05. An estimate, not holdings: it can't name stocks.
· : 0.59 · Too loose a fit for a verdict; shown as a guide.
Beta to the S&P 500: 0.83 (90%: 0.73 to 0.97)
Compares the stated rules with the holdings (or, where none are published, a mix estimated from returns), using tests fixed before any results were seen.
No holdings on file, so nothing to test.
Strategies that share its Alternative data label, from other sources first, strongest risk-adjusted return first.
Composer Technologies · Composer
Collective2
How much of what we look for this strategy has, and why anything is missing. Fields that don't apply to it aren't counted.
4 missing
The text the rules are quoted from, with where it came from.
Companies with the highest quarter-over-quarter growth in corporate lobbying expenditures
The Lobbying Disclosure Act of 1995 requires lobbyists in the United States to disclose information about their activities, such as their clients, which issues they are lobbying on, and how much they are being paid. This data is scrapped and mapped to stock tickers to track which companies are spending money for legislative influence. Focusing on companies with a sudden increase in lobbying expenditures has historically been able to identify companies poised to benefit from favorable legislation and deliver excess returns. This portfolio is rebalanced at the start of every month.
We use a rolling window for lobbying disclosures in an attempt to capture the full quarter’s lobbying expenditure. Large lobbying disclosures for a company on the same issue are often done quarterly with a semi-consistent interval, so there is potential for a company to move out of the rankings for one (or more) rebalance periods if the two disclosures are spread out, and conversely for a company to move into the ranking during a rebalance window if the two disclosures are closer together.
Lobbying disclosures are filed under a company’s legal name, and are not mapped to tickers at the source. Because of this, there is a risk of mapping lobbying disclosures to the wrong company, or missing disclosures that are filed under a subsidiary or other name. While we have taken steps to mitigate this risk, it presents the possibility for erroneous data. This strategy invests in fractional shares when available. When not available, it will invest in the nearest (lower) whole number of shares. Please note that this number may be 0 if your investment in this strategy is sufficiently low, meaning our investment strategy advertised returns will be different from your returns.
This strategy takes an equal-weighted position in 10 publicly-traded companies that disclosed the most Quarter over Quarter growth in U.S. federal lobbying expenditures
Every value on file, each labelled with its calculation basis and as-of date.
| Last rebalance date | 2026-10-01 | 2026-10-05 | |
| Rebalance frequency | monthly | 2026-10-05 |
| Brokerage / custodian | Alpaca | 2026-10-05 | |
| Management / advisory fee | 1.00% |
| Metrics calculated through | 2026-10-05 | 2026-10-05 |
| Partner (Quantbase data field) | quiverquant | 2026-10-05 | |
| Program in the firm's Form ADV brochure | url: https://files.adviserinfo.sec.gov/IAPD/Content/Common/crd_iapd_Brochure.aspx?BRCHR_VRSN_ID=1043543 · name: Lobbying Spending Growth Stock Tracker · covers: 1 · source_key: quantbase_surmount|17 · original_name: Lobbying Spending Growth |
| Correlation to SPY (Quantbase data field) (basis not stated) | 0.74 | 2026-10-05 | |
| Correlation to SPY (full history) (client composite) | 0.74 | 2026-10-05 |
| Annual return (Quantbase data field) (basis not stated) | 22.91% | 2026-10-05 | |
| Backtest end date (Quantbase data field) | 2022-11-01 | 2026-10-05 | |
| Return since chart start (cumulative) (client composite) | 67.44% | 2026-10-05 | |
| Return, rolling 1 year (client composite) | 29.78% | 2026-10-05 |
| Daily volatility over the chart range (client composite) | 1.09% | 2026-10-05 | |
| Max drawdown over the chart range (client composite) | -33.13% | 2026-10-05 | |
| Monthly volatility over the chart range (client composite) | 5.48% | 2026-10-05 | |
| Sharpe ratio from daily returns over the chart range (client composite) | 0.74 | 2026-10-05 | |
| Volatility over the chart range, annualized from daily (×√252) (client composite) | 17.30% | 2026-10-05 |
| Qualitative risk score (Quantbase data field) | 4 | 2026-10-05 | |
| Risk score 0-5 (Quantbase) | 3.50 | 2026-10-05 |
| Experience minimum: bonds | 0 | 2026-10-05 | |
| Experience minimum: crypto | 0 | 2026-10-05 | |
| Experience minimum: equity | 0 | 2026-10-05 | |
| Experience minimum: leverage | 0 | 2026-10-05 | |
| Experience minimum: options | 0 | 2026-10-05 |
Quantbase · Surmount
